BURNABY, British Columbia--(BUSINESS WIRE)--Dexcom, Inc. (NASDAQ: DXCM), a global leader in real-time continuous glucose monitoring (rtCGM) for people with diabetes, announced today that its latest ...
MSN による配信
Diabetics at Risk: FDA Issues Highest-Level Recall on 2M Dexcom Devices Over 'Deadly Fault'
The US Food and Drug Administration (FDA) has issued its highest-level recall on more than two million Dexcom Continuous Glucose Monitoring (CGM) devices, warning diabetic patients and healthcare ...
一部の結果でアクセス不可の可能性があるため、非表示になっています。
アクセス不可の結果を表示する